Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.

Stanford is now accepting new patients for this trial. Please contact Alexander Ungewickell at 650-723-6661 for more information.

Investigator(s):

Phase: N/A

Eligibility

Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

- 18 years of age or older - Patient meets the clinical and/or pathologic criteria for the cutaneous or hematologic disorder being examined. - Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.

External Links

Explore related trials

Contact information

Primary Contact:

Alexander Ungewickell 650-723-6661

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: